マイクロアレイの市場規模、シェア、成長分析、製品・サービス別、タイプ別、用途別、最終用途別、地域別- 産業予測、2024～2031年

マイクロアレイの世界市場規模は、2022年に51億米ドルと評価され、2023年の54億9,000万米ドルから2031年には99億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは7.7%で成長する見通しです。

マイクロアレイ技術は、ゲノミクスの分野で重要な役割を果たし、多数の核酸を表面に結合させることにより、ハイブリダイゼーションを通じて相対的な核酸配列濃度の測定を可能にします。この革新的なアプローチは、クロマチン免疫沈降法と組み合わせることで、遺伝子発現レベルの定量や転写因子結合部位の特定に特に有用です。マイクロアレイは、生物学者に豊富で複雑なデジタルデータを提供する初期の技術の一つとして、依然として重要な役割を果たしています。特に、未処理データや処理済みデータが登場し、これらが広範な解析やメタ解析をサポートすることにより、その重要性はますます高まっています。Function Genomics Data Societyによって確立されたMIAME標準は、マイクロアレイ研究における高品質で一貫性のある報告を保証し、最終的に今後の予測期間におけるマイクロアレイ技術の需要を促進します。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

マイクロアレイの市場規模：製品・サービス別& CAGR（2024-2031）

• 市場概要
• 消耗品
• 機器
• ソフトウェアとサービス

マイクロアレイの市場規模：タイプ別& CAGR（2024-2031）

• 市場概要
• DNAマイクロアレイ
• タンパク質マイクロアレイ
• その他

マイクロアレイの市場規模：用途別& CAGR（2024-2031）

• 市場概要
• 研究用途
• 創薬
• 病気の診断
• その他の用途

マイクロアレイの市場規模：最終用途別& CAGR（2024-2031）

• 市場概要
• 調査・学術機関
• 製薬・バイオテクノロジー企業
• 診断検査室

マイクロアレイの市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Illumina, Inc.（USA）
• Agilent Technologies, Inc.（USA）
• Thermo Fisher Scientific, Inc.（USA）
• Merck KGaA（Germany）
• PerkinElmer, Inc.（USA）
• Arrayit Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• GE Healthcare（UK）
• Molecular Devices, LLC.（USA）
• Affymetrix（USA）
• RayBiotech Life, Inc.（USA）
• Full Moon BioSystem, Inc.（USA）
• CapitalBio Technology Co., Ltd.（China）
• Microarray Inc.（USA）
• QIAGEN（Netherlands）
• Roche NimbleGen（USA）
• Applied Microarrays（USA）
• bioMerieux SA（France）
• Discerna（USA）
• Gyros AB（Sweden）

結論と推奨事項

Global Microarray Market size was valued at USD 5.1 billion in 2022 and is poised to grow from USD 5.49 billion in 2023 to USD 9.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Microarray technology remains pivotal in the genomics landscape, allowing for the binding of numerous nucleic acids to a surface, which facilitates the measurement of relative nucleic acid sequence concentrations through hybridization. This innovative approach is particularly valuable for quantifying gene expression levels and pinpointing transcription factor binding sites when paired with chromatin immunoprecipitation. As one of the earliest technologies offering biologists a wealth of complex digital data, microarrays continue to play a crucial role, especially with the advent of raw and processed data that supports extensive analysis and meta-analyses. The MIAME standards established by the Function Genomics Data Society ensure high-quality, consistent reporting in microarray research, ultimately driving demand for microarray technology in the upcoming forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microarray market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microarray Market Segmental Analysis

Global Microarray Market is segmented by product and services, type, application, end use and region. Based on product and services, the market is segmented into consumables, instruments and software and services. Based on type, the market is segmented into DNA microarray, protein microarray and others. Based on application, the market is segmented into research applications, drug discovery, disease diagnostics and others applications. Based on end use, the market is segmented into research and academic institutes, pharmaceutical and biotechnology companies and diagnostic laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microarray Market

Global Microarray is a cutting-edge technology designed for high-throughput analysis of gene expression, enabling researchers to investigate the complexities of genomic data rapidly and efficiently. This driver provides an interface for seamless integration with existing bioinformatics pipelines, allowing users to preprocess, analyze, and visualize microarray data effortlessly. With its intuitive functionality, users can easily load raw data, apply normalization techniques, perform differential expression analysis, and generate insightful visualizations such as heatmaps and volcano plots. Furthermore, the driver supports various data formats and harmonizes with popular statistical packages, ensuring compatibility and fostering reproducibility in genetic research and clinical studies.

Restraints in the Global Microarray Market

Global Microarray is a powerful biotechnology company leveraging cutting-edge microarray technology for genomic analysis. However, its expansion is restrained by several factors, including regulatory hurdles associated with genetic testing and data privacy concerns. Furthermore, the high cost of microarray technology can limit accessibility for smaller laboratories and institutions, potentially stifling research innovation. The competitive landscape, with rapid advancements in alternative genomic sequencing technologies, poses an additional challenge to maintaining market leadership. Lastly, the reliance on skilled personnel and specialized training necessitates a continuous investment in human resources, which can strain operational budgets and affect long-term sustainability.

Market Trends of the Global Microarray Market

The global microarray market is experiencing dynamic trends driven by the need for personalized medicine and precision diagnostics. As the demand for genetic analysis and profiling escalates, advancements in genomics research and understanding of genetic variations are propelling microarray technology to the forefront. Additionally, the industry is witnessing a significant shift toward multiplexing and high-throughput analysis, allowing researchers to evaluate thousands of genes or proteins simultaneously, thereby enhancing efficiency and reducing costs. Furthermore, the focus on biomarker discovery and validation is intensifying, as microarrays play a crucial role in identifying potential biomarkers for early disease detection and targeted therapies, further propelling market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microarray Market Size by Product and Services & CAGR (2024-2031)

• Market Overview
• Consumables
• Instruments
• Software and Services

Global Microarray Market Size by Type & CAGR (2024-2031)

• Market Overview
• DNA Microarray
• Protein Microarray
• Others

Global Microarray Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Drug Discovery
• Disease Diagnostics
• Others Applications

Global Microarray Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories

Global Microarray Market Size & CAGR (2024-2031)

• North America (Product and Services, Type, Application, End Use)
  • USA
  • Canada
• Europe (Product and Services, Type, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Services, Type, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Services, Type, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Services, Type, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arrayit Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Devices, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Life, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Full Moon BioSystem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapitalBio Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microarray Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche NimbleGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Microarrays (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discerna (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gyros AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations